Business Context and Reporting Period
Company: Bristol-Myers Squibb Company (BMY)
Filing Type: Form 8-K (Current Report)
Reporting Period: Second Quarter 2026
Date of Report: July 30, 2026
This filing serves as a notification that the Company issued an Earnings Press Release and a presentation regarding its financial results for the second quarter of 2026. The detailed financial data is contained within the attached exhibits (Exhibit 99.1 and 99.2) and is not explicitly detailed in the body of this 8-K form.
Key Financial Metrics
The text of this Form 8-K does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are referenced as being available in the Earnings Press Release (Exhibit 99.1) and the Bristol Myers Presentation (Exhibit 99.2).
- Revenue/Profit: Not stated in filing text; see Exhibit 99.1.
- Cash Flow/Liquidity: Not stated in filing text; see Exhibit 99.1.
- Debt: Not stated in filing text; see Exhibit 99.1.
- Margins: Not stated in filing text; see Exhibit 99.1.
Material Changes
The filing does not contain specific data regarding material changes versus the prior comparable period. Investors must refer to the incorporated Earnings Press Release for year-over-year comparisons and operational updates.
Guidance, Outlook, and Risks
Management Commentary: The Company posted a presentation on its website detailing financial and operating initiatives available during the conference call held on July 30, 2026, at 8:15 a.m. Eastern time.
Non-GAAP Measures: The Earnings Press Release and Presentation include non-GAAP financial information. Reconciliations to GAAP measures are provided in Exhibit 99.1.
Legal Disclaimer: Pursuant to General Instruction B.2, the information in Item 7.01 (including the presentation) is not deemed "filed" under the Exchange Act and is not subject to Section 18 liabilities, nor is it incorporated by reference into future filings unless specifically stated.
Investor Verification Checklist
- Review Exhibit 99.1 (Earnings Press Release) for specific Q2 2026 revenue, net income, and EPS figures.
- Examine Exhibit 99.2 (Presentation Materials) for management's outlook and operating initiatives.
- Verify the reconciliation between non-GAAP and GAAP financial measures provided in the press release.
- Confirm the availability of the presentation on the Company's website, noting the Company reserves the right to discontinue access at any time.